IAVI-Report-03(3)

In this issue:

• HIV DNA vaccines move slowly into human trials
• IAVI Launches Scientific Blueprint
• The Outlook for Key HIV DNA Vaccine Programs
• An Interview with Margaret Liu
• AIDS in South Africa
• South Africa's Explosive AIDS Epidemic
• VaxGen gets Approval for U.S. Efficacy Study
• Industry Insider
• Vaccine Briefs